Morphogenesis, Inc. Is Testing Cancer Vaccine

Scientists at UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, call the “therapeutic vaccine” a simple and safe technology that could help people who already have cancer fight it off.

Six patients with stage three and stage four melanoma started the trial in November 2018. Morphogenesis, Inc., is working with specialists at Moffitt Cancer Center to give them an injection right into their skin lesions.